GLOBAL STAR ACQ INC A by Global Star Acquisition, Inc. Azioni (OTC: GLST)

Ultime notizie per GLOBAL STAR ACQ INC A by Global Star Acquisition, Inc. (OTC:GLST) Azioni

GLOBAL STAR ACQ INC A by Global Star Acquisition, Inc.

GLOBAL STAR ACQUISITION INC RT

Global Star Acquisition Inc Units (1 Ord Class A, 1 War & 1 Right)

Global Star Acquisition Inc Warrants(15/07/2028)

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.amwater.com%2F&amp;esheet=54257067&amp;newsitemid=20250519975285&amp;lan=en-US&amp;anchor=American+Water+Works+Company%2C+Inc.&amp;index=1&amp;md5=de5ccdd2193ab0766db1e1614b5f3409">American Water Works Company, Inc.</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AWK#NYSE">AWK</a>), the largest regulated water and wastewater utility company in the U.S., announced today that it has agreed with Nexus Regulated Utilities, LLC, a subsidiary of Nexus Water Group, Inc. ("Nexus Water Group"), to purchase multiple water and wastewater systems located in eight states for a total of approximately $315 million, subject to adjustment as provided for in the purchase and sale agreement.
Based on current connection counts, the acquisition would add nearly 47,000 customer connections within American Water's existing footprint in Illinois, Indiana, Kentucky, Maryland, New Jersey, Pennsylvania, Tennessee and Virginia.
The transaction will require regulatory approval by the state public utility commissions in applicable states, as well as other customary approvals from other governmental entities, and both American Water and Nexus Water Group are committed to working together to ensure that the transition will be seamless for customers after the acquisition and beyond. American Water is also committed to offering employment to the approximately 70 employees of Nexus Water Group affiliates who proudly provide water and wastewater service in these areas.
The completion of the transaction is also subject to the satisfaction or waiver of various conditions, including the receipt of all required regulatory approvals and other customary closing conditions. The estimated closing will take place by or before August 2026.

News

American Water Works Agrees With Nexus Regulated Utilities To Purchase Multiple Water And Wastewater Systems In Eight States For About $315M

Investors poured billions into long-dated U.S. Treasury ETFs in the days leading up to Moody's credit rating downgrade—raising fresh doubts over whether that confidence can endure <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45500872/30-year-treasury-yields-hit-5-what-that-means-for-stocks">as debt risks deepen.</a>
The iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>)—the world&#8217;s biggest fixed-income ETF—attracted $2.07 billion in inflows between May 12 and May 16, according to ETFdb.com flow data. This is the largest weekly haul since November 2024 and the second biggest since June 2024.
Other long-duration Treasury ETFs also recorded notable inflows last week:
The Direxion Daily 20-Yr Treasury Bull 3x Shares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMF#NYSE">TMF</a>)—which offers triple-leveraged exposure to 20-year Treasury bonds—attracted $470 million, its largest weekly inflow since November 2024, signaling a surge in leveraged bullish bets on long-term rates.
Meanwhile, the PIMCO 25+ Year Zero Coupon U.S. Treasury ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZROZ#NYSE">ZROZ</a>) pulled in $32.8 million, marking its strongest week of inflows since January 2025.
The timing is notable: the surge in demand preceded Friday's Moody's downgrade, which cut the U.S. sovereign rating to Aa1 from Aaa, citing chronic deficits, rising debt servicing costs, and a bleak fiscal outlook heading toward deficits near 9% of GDP by 2035, should the Tax Cuts and Jobs Act be extended.
Still, year-to-date long-dated Treasury ETFs have seen more outflows than inflows. The iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) witnessed $1.2 billion in outflows, positioning 2025 to potentially become the first year of net withdrawals since 2020. 
<h3 class="wp-block-heading">Tariff Truce Sparked Optimism, Reduced Recession Odds </h3>
Part of the inflows into long-dated Treasuries may have been fueled by a major U.S.-China trade breakthrough, with both sides agreeing to slash tariffs by 115 percentage points—a move that sparked a rally in risk assets and lowered perceived recession risks.
Last week's economic tone was notably risk-on – bolstered by two cooler-than-expected inflation reports – and investors, anticipating stability in interest rates and soft-landing potential, re-entered duration trades in Treasury markets. Long bonds typically perform well when growth fears ease and the market sees room for rate cuts.
<h3 class="wp-block-heading">Moody's Downgrade Adds Tension—But No Panic</h3>
Despite the downgrade, the market response was measured on Monday. The 30-year Treasury yield briefly spiked above 5% on Monday before falling back to 4.92% as demand resurfaced.
The TLT ETF inched 0.3% lower, signaling that while sentiment slightly weakened, there was no panic selling.
"Friday&#8217;s U.S. sovereign downgrade by Moody&#8217;s is unlikely to result in forced selling but may worsen UST sentiment," said Bank of America analyst Mark Cabana in a note.
Yet, several analysts across Wall Street have largely downplayed the immediate impact of the downgrade. 
Further, regulatory frameworks—such as the Basel III capital standards—continue to treat U.S. Treasuries rated AAA to AA- as risk-free for capital requirement purposes. 
This means banks and institutional investors face no changes in how they treat U.S. government bonds, reinforcing the structural role Treasuries play as collateral and liquidity instruments globally.
The appetite for duration remains intact—for now—but whether investors continue pouring in as fiscal risks take center stage remains to be seen.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45497403/is-the-dollars-global-reserve-role-at-risk-after-moodys-downgrade">Is The Dollar&#8217;s Global Reserve Role At Risk After Moody&#8217;s Downgrade? </a></li>
</ul>
Photo: Shutterstock

Analyst Color

Bonds

Specialty ETFs

Treasuries

Analyst Ratings

ETFs

iShares Trust Barclays 20+ Year Treasury Bond Fund

Direxion Daily 20+ Year Treasury Bull 3X Shares

PIMCO 25+ Year Zeroupon US Treasury Index Fund

ZROZ

Investors Piled Into Long-Term Treasury ETFs Ahead Of Moody's Downgrade: Will Confidence Hold?

PFAI

Pinnacle Food Group Receives Noncompliance Nasdaq

8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) is looking for FY2026 Adj EPS of $0.34-$0.37 vs $0.36 analyst estimate. Widens FY2025 sales outlook from $713.00 million-$719.00 million to $702.00 million-$724.00 million vs $715.88 million estimate.

Guidance

EGHT

8x8 Sees FY2026 Adj EPS $0.34-$0.37 vs $0.36 Est; Widens FY2025 Sales Guidance from $713.00M-$719.00M to $702.00M-$724.00M vs $715.88M Est

8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) is looking for Q1 Adj EPS of $0.07-$0.09 vs $0.09 analyst estimate. Widens Q1 sales outlook from $176.00 million-$181.00 million to $175.00 million-$182.00 million vs $178.88 million estimate.

8x8 Sees Q1 Adj EPS $0.07-$0.09 vs $0.09 Est; Widens Q1 Sales Guidance from $176.00M-$181.00M to $175.00M-$182.00M vs $178.88M Est

SEGA SAMMY Nears Completion Of Procurement Of All Gaming Regulatory Approvals To Acquire GAN

Agilysys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) sees FY2026 sales of $308.000 million-$312.000 million vs $318.84 million analyst estimate.

AGYS

Agilysys Sees FY2026 Sales $308.000M-$312.000M vs $318.84M Est

8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) reported quarterly earnings of $0.08 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $177.04 million which missed the analyst consensus estimate of $177.84 million by 0.45 percent. This is a 1.32 percent decrease over sales of $179.41 million the same period last year.

Earnings

Earnings Misses

8x8 Q4 Adj. EPS $0.08, Inline, Sales $177.04M Miss $177.84M Estimate

Ryman Hospitality Properties To Acquire JW Marriott Phoenix Desert Ridge Resort & Spa For $865M

Biotech

General

TRML

Tourmaline Bio To Present Topline Results From The Phase 2 TRANQUILITY Trial Evaluating Pacibekitug In Patients With Elevated High-Sensitivity C-Reactive Protein And Chronic Kidney Disease On May 20, 2025

<ul>
<li>$150 million secured at closing extends cash runway into early 2027</li>
<li>REGENXBIO retains additional potential non-dilutive funding opportunities, including monetization of Priority Review Voucher (PRV) and milestones from AbbVie</li>
</ul>
ROCKVILLE, Md., May 19, 2025 /PRNewswire/ --&nbsp;REGENXBIO Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGNX#NASDAQ">RGNX</a>) today announced the closure of a non-dilutive, limited recourse royalty bond agreement of up to $250 million with Healthcare Royalty (HCRx). This agreement monetizes select anticipated royalties and milestones, and provides both immediate and expected future, non-dilutive capital. &nbsp;REGENXBIO received $150 million at closing, extending the Company's expected cash runway into early 2027.

RGNX

REGENXBIO Announces Closure Of Non-Dilutive, Limited Recourse Royalty Bond Agreement Of Up To $250M With Healthcare Royalty

WIIM

TRNS

Transcat shares are trading higher after the company reported better-than-expected Q4 financial results.

Earnings Beats

Safe Bulkers Q1 Adj. EPS $0.05 Beats $0.03 Estimate, Sales $64.35M Beat $57.92M Estimate

The Financial Arrangement with CounterpointeSRE and Barings also Includes an Expected Issuance of a Second Series of Notes, an Additional Uncommitted $300 Million Shelf Facility and a Tax Credit Purchase Agreement for Future Ameresco Energy Assets

Financing

AMRC

Ameresco Announces $78M Facility For Battery Storage Energy Asset Financing

First Oral Presentation of the Tanruprubart Real-World Evidence (RWE) Study by International Guillain-Barré Syndrome Outcomes Study (IGOS) Researchers Highlights Benefits over Current Standard of Care in Matched Patient Populations
Poster Presentations on New Pivotal Phase 3 Analyses Underscore Tanruprubart's Rapid and Sustained Treatment Effect and Improvement in Quality of Life Compared to Placebo

Events

ANNX

Annexon Presents Data Highlighting Outcomes With Tanruprubart At 2025 Peripheral Nerve Society Annual Meeting

Agilysys Q4 Adj. EPS $0.54 Beats $0.29 Estimate, Sales $74.27M Beat $71.42M Estimate

CLRO

ClearOne Q1 Adj. EPS $(0.11) Down From $(0.07) YoY, Sales $2.31M Down From $3.62M YoY

Alpha Tau Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRTS#NASDAQ">DRTS</a>) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.13) by 7.69 percent. This is a 9.09 percent decrease over losses of $(0.11) per share from the same period last year.

DRTS

Alpha Tau Medical Q1 EPS $(0.12) Beats $(0.13) Estimate

Transcat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNS#NASDAQ">TRNS</a>) reported quarterly earnings of $0.64 per share which beat the analyst consensus estimate of $0.37 by 72.97 percent. This is a 3.03 percent decrease over earnings of $0.66 per share from the same period last year. The company reported quarterly sales of $77.13 million which beat the analyst consensus estimate of $76.39 million by 0.97 percent. This is a 8.77 percent increase over sales of $70.91 million the same period last year.

Transcat Q4 Adj. EPS $0.64 Beats $0.37 Estimate, Sales $77.13M Beat $76.39M Estimate

Educational Development (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDUC#NASDAQ">EDUC</a>) reported quarterly losses of $(0.16) per share. This is a 15.79 percent increase over losses of $(0.19) per share from the same period last year. The company reported $6.64 million in sales this quarter. This is a 26.00 percent decrease over sales of $8.97 million the same period last year.

EDUC

Educational Development Q4 EPS $(0.16) Up From $(0.19) YoY, Sales $6.64M Down From $8.97M YoY

Management

Press Releases

K Enter Holdings Inc. Announces Leadership Transition

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Global Star Acquisition Inc. - GLST

Global Star Acquisition Inc. and K Enter Holdings Inc. Announce the Form F-4 Registration Statement for Their Proposed Business Combination has been Declared Effective

Comments

GLOBAL STAR ACQ INC A by Global Star Acquisition, Inc.

Notizie

Ultime notizie per GLOBAL STAR ACQ INC A by Global Star Acquisition, Inc. (OTC:GLST) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO